
Hong Kong’s Phase Scientific gets US$34 million to advance test for cancer risk factor HPV
Hong Kong’s Phase Scientific International (PSI) has raised US$34 million from private investors to further develop a non-invasive test for human papillomavirus (HPV), a major cause of cervical cancer. The test developed by the Hong Kong Science and …